Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • Ritobegron - Spinal Cord Injuries
    Clinical Study Number 1207.4
    Study Indication Spinal Cord Injuries
    Product Ritobegron
    Generic Name Ritobegron
    Lab Code
    Clinical Phase I
    Study Title

    A phase I, randomised, double-blind, placebo-controlled study to determine pharmacodynamic effects and pharmacokinetics of a single oral dose of 320 mg KUC-7483 CL in patients with spinal cord injury and neurogenic detrusor overactivity

    Study Document
    Trial synopsis 1207.4 english